News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Drug Development
AstraZeneca PLC (JOBS), Sanofi (France) (JOBS), Merck & Co., Inc. Heart Drugs Cut Alzheimer’s Disease
January 14, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Drugs commonly used to lower blood pressure, sold by AstraZeneca Plc, Sanofi-Aventis SA and Merck & Co., may also reduce the risk of developing Alzheimer’s disease.
Twitter
LinkedIn
Facebook
Email
Print
Clinical research
Phase III
Postmarket research
AstraZeneca Pharmaceuticals LP
Merck & Co.
Sanofi (France)
MORE ON THIS TOPIC
Gene therapy
Sarepta Provides New Elevidys Safety Data, Reveals Zero Ambulatory Deaths
August 13, 2025
·
2 min read
·
Tristan Manalac
Lung cancer
140-Year-Old Boehringer Ingelheim Dives Into Cancer With NSCLC Nod
August 11, 2025
·
2 min read
·
Tristan Manalac
IN PARTNERSHIP WITH TOZARO
The Future of Cell and Gene Therapy: Navigating Innovation, Regulation, and Manufacturing Challenges
August 11, 2025
·
8 min read
·
BioSpace Insights
Opinion
Opinion: Antagonism to mRNA Technology Is Killing Our Best Shot At a Cure For Cancer
August 11, 2025
·
6 min read
·
Jonathan Kagan, PhD